Tenon Medical Reports Strong Q4 & FY25 Results: Revenue Up 92% in Q4, Gross Profit Jumps 188%
TNON sits 28% above its 52-week low of $0.641.
Summary
Tenon Medical announced robust financial results for Q4 and FY2025, featuring strong revenue growth, improved gross profitability, and a narrowed net loss, alongside FDA clearance for a new product.
Key Events · Earnings and Guidance · TNON
-
Strong Revenue Growth Reported
Fourth quarter 2025 revenue increased 92% year-over-year to $1.5 million, contributing to a 20% full year 2025 revenue increase to $3.9 million.
-
Significant Gross Profit and Margin Improvement
Gross profit for Q4 2025 surged 188% to $1.0 million, with gross margin expanding to 69%. Full year gross profit rose 38% to $2.4 million, with gross margin at 60%.
-
Net Loss Narrowed
The company's net loss for Q4 2025 narrowed to $2.8 million from $3.1 million in the prior year, and full year net loss decreased to $12.6 million from $13.7 million.
-
FDA Clearance for Next-Generation Product
Tenon Medical secured FDA 510(k) clearance for its next-generation SImmetry+ SI Joint Fusion System, expanding its product portfolio and addressable market.
Analysis · TNON · Industrial Applications And Services
Tenon Medical, a micro-cap company, reported significant operational improvements for the fourth quarter and full fiscal year 2025. The substantial revenue growth, particularly the 92% increase in Q4, coupled with a dramatic 188% rise in Q4 gross profit and improved margins, indicates strong momentum and enhanced operating leverage. The reduction in net loss, alongside the FDA clearance for a new product, signals positive progress in both commercial execution and product development. While the cash balance decreased year-over-year, the company has recently secured additional capital through a PIPE financing and convertible notes, which should support continued growth initiatives and strengthen its financial runway.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.6% of the 1569 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TNON was trading at $0.82 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.3M. The 52-week trading range was $0.64 to $5.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.